Cannabis Use Disorder: Recognizing the Signs of Marijuana Addiction
Cannabis has undergone a dramatic transformation in the public eye—from stigmatized contraband to a widely accepted substance, often marketed as benign or even medicinal. While its therapeutic benefits for certain conditions are legitimate, a less discussed truth persists: cannabis can be addictive. Cannabis Use Disorder (CUD) is a recognized mental health diagnosis with real consequences for those affected. Awareness of its signs is the first step toward meaningful intervention.
Understanding the Link Between Stimulants and Attention Disorders
Some individuals with ADHD may experience temporary relief from symptoms when using stimulants, but it's important to understand the distinction between medical treatments and harmful substances. Methamphetamine is a powerful and highly addictive stimulant that affects the brain's dopamine system, similar to prescription medications like Adderall,does meth help with adhd which are used to treat ADHD. However, while prescription stimulants are carefully dosed and monitored, meth is illegal and dangerous. Although people may believe meth helps with ADHD, it often leads to severe side effects, addiction, and long-term cognitive damage, making it an unsafe and ineffective treatment option.
Defining Cannabis Use Disorder
Cannabis Use Disorder is not mere overindulgence. According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), it is characterized by a cluster of behavioral, physical, and psychological symptoms reflecting impaired control over use. Individuals with CUD may persist in their consumption despite significant personal, social, or professional disruption. The line between recreational use and disorder is often subtle, obscured by normalization and denial.
Dependence develops when the user experiences both tolerance and withdrawal. Tolerance demands higher doses to achieve the desired effect, while withdrawal manifests when cessation leads to discomfort or dysfunction. These signs, when coupled with continued use, form the clinical foundation of addiction.
Behavioral and Psychological Signs of Cannabis Addiction
The behavioral patterns of CUD frequently begin with increased frequency. What starts as occasional use may escalate to daily or near-daily consumption. Users may express intentions to reduce their intake, only to relapse repeatedly. This cycle of attempted restraint and resumed use signals a loss of control.
Psychologically, the individual may exhibit blunted ambition—a phenomenon colloquially dubbed 'amotivational syndrome.' Tasks once pursued with vigor now seem burdensome. Apathy replaces curiosity. Emotionally, cannabis dependency often breeds irritability, anxiety, or even mild paranoia. Thoughts may feel foggy, attention drifts, and short-term memory deteriorates. These symptoms do not exist in isolation; they interact, compounding dysfunction.
Physical Indicators of Chronic Cannabis Use
Though often viewed as non-threatening, chronic marijuana use can leave a physiological imprint. Inhalation of cannabis—particularly when combusted—can inflame the lungs, leading to chronic bronchitis-like symptoms: persistent coughing, wheezing, and phlegm production.
Sleep architecture is also affected. While cannabis may initially induce drowsiness, prolonged use disrupts REM cycles, resulting in non-restorative sleep or even insomnia. Appetite patterns may also become dysregulated. Some individuals experience excessive hunger (the classic 'munchies'), while others notice erratic food intake.
Withdrawal from cannabis, though often milder than that of opioids or alcohol, is nonetheless significant. Users may report tremors, restlessness, irritability, intense cravings, or gastrointestinal distress within 24–72 hours of cessation.
Impact on Daily Functioning and Relationships
As dependence deepens, the effects on daily life become undeniable. Academic performance may slip as concentration wanes. Job responsibilities are neglected. Timeliness and reliability erode. In some cases, individuals abandon pursuits they once valued, such as hobbies or creative endeavors.
Social relationships often bear the brunt. Users may withdraw from loved ones, preferring solitude or only associating with fellow users. Deception around use becomes common—hiding cannabis, minimizing quantity, or becoming defensive when questioned. Responsibilities—whether domestic, financial, or familial—are routinely postponed or disregarded altogether.
Risk Factors for Developing Cannabis Use Disorder
Not everyone who uses cannabis will develop CUD. Certain factors, however, raise the risk. A family history of addiction suggests a genetic vulnerability. Co-occurring mental health conditions, particularly anxiety, depression, and attention disorders, increase susceptibility.
The age of initial use plays a pivotal role. Adolescents and young adults are especially at risk, as their brains are still undergoing critical developmental changes. Additionally, today's cannabis strains, often cultivated to yield high THC concentrations, possess greater addictive potential than earlier iterations. Social environments that normalize or glamorize heavy use can reinforce unhealthy patterns.
When to Seek Help and Available Treatment Options
One of the most insidious aspects of CUD is the denial that often accompanies it. Users may dismiss their behavior as harmless or deny the extent of their dependency. However, once the patterns begin to interfere with quality of life, it is time to take action.
Therapeutic interventions are available and effective. Cognitive Behavioral Therapy (CBT) is commonly used to address underlying thought patterns that drive compulsive use. Motivational Enhancement Therapy (MET) helps increase internal drive toward recovery. In some cases, contingency management—offering rewards for sobriety—has shown promise.
Long-term recovery may also involve group therapy, mindfulness practices, and lifestyle restructuring. The journey is rarely linear. Relapse can occur. But with proper support, lasting recovery is achievable.
Understanding the Differences Between Two Dangerous Drugs
While meth and crack are both powerful and highly addictive stimulants, they are not the same. Meth, short for methamphetamine, is a synthetic drug often found in pill or powder form, while crack is a smokable form of cocaine made by processing cocaine hydrochloride with baking soda or ammonia. Each affects the brain differently—meth releases large amounts of dopamine, causing long-lasting highs,are meth and crack the same whereas crack produces intense but short-lived euphoria. Although both substances are harmful, meth tends to cause more severe long-term neurological damage. Understanding the differences between meth and crack is essential for recognizing their unique risks.
Conclusion
Cannabis Use Disorder is a legitimate, clinically recognized condition that merits serious attention. It is not confined to stereotypes or extremes. It can affect high-functioning professionals, students, and creatives alike. Recognizing the signs early allows for timely intervention and more successful outcomes. With the right treatment and support, individuals struggling with CUD can regain clarity, motivation, and control over their lives. Compassion—not judgment—is the foundation of healing.
TIME BUSINESS NEWS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
a day ago
- Newsweek
More Seniors Are Using Drugs—Here's Why It Matters
Advocates for ideas and draws conclusions based on the interpretation of facts and data. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. For decades, Americans worried about their kids getting high. Now, alarming new data suggest they should be just as worried about their parents and grandparents—and demanding that their legislators and policymakers take immediate action to stop the rising tide of marijuana use among seniors. A study out this month from JAMA Internal Medicine shows an enormous jump in the rate of past-month pot use among Americans 65 years and older; from 2021 to 2023 it increased nearly 46 percent. This is not some statistical fluke. The study looked at the drug-use habits of almost 16,000 older adults nationwide, across gender, race, and income and educational levels. And the data show sharp increases across almost all demographics. In other words, it doesn't seem to matter much who these seniors are. They're using more weed. Yes, the news has rightly generated some media ripples. But the response has so far been muted in comparison with the magnitude of the problem. Where are the calls for senior-focused prevention? This is no different, after all, from a near-50 percent jump in teen use over two years. The fact that these are in general older people doesn't make the finding any less worrying. The rest of the bad-news drumbeat around marijuana and public health shows why increased use among older people should set major alarms ringing. A May study led by researchers at the University of California San Francisco showed that marijuana is terrible for your heart (whether you smoke it or eat it). Research published in the Journal of the American Heart Association found daily marijuana users had a 42 percent increased risk of stroke and a 25 percent increased risk of heart attacks—even after adjusting for other factors including tobacco use. Adults with Cannabis Use Disorder are 60 percent more likely to experience heart failure, strokes, or heart attacks than adults who do not use marijuana. Plus, daily users are more at risk for certain cancers, including head, neck, and laryngeal cancers. How many of the 65-plus set are aware of these risks? They should be common knowledge among all age groups, but especially older people. Available data suggest that having reached your golden years doesn't in any way protect you from the horrible risks of using marijuana. In Ontario, hospital admissions and emergency room visits related to marijuana jumped 26-fold among people 65 and older between 2008 and 2021; between 2005 and 2019, the rate of marijuana-related emergency-room visits in California for that group rose almost 19-fold. LOS ANGELES, CALIFORNIA - MAY 24: In this photo illustration, marijuana joints and buds, also known as 'flower', are viewed on May 24, 2024 in Los Angeles, California. LOS ANGELES, CALIFORNIA - MAY 24: In this photo illustration, marijuana joints and buds, also known as 'flower', are viewed on May 24, 2024 in Los Angeles, disturbingly, the Ontario study also showed that anyone going to the hospital for marijuana suffers a 72 percent higher risk of dementia than the general population. As more and more data emerge, it's becoming clearer that seniors represent an at-risk population for this drug, just as much as kids do. One of the truly disturbing data points from the JAMA study is that among older adults with post-college education, past-month use increased almost 70 percent. For adults earning more than $75,000 annually, it more than doubled. If the most educated and affluent segments of the most experienced and knowledgeable population have fallen for propaganda around the drug, everybody interested in restoring public health really has their work cut out for them. So what should be the response? First up is a prevention campaign aimed at older people. That may sound counterintuitive, and it would require different messaging than the powerful teen-targeted federal communications push on the issue from the '90s. An emphasis on the damage the drug does to heart health makes sense as a touchpoint. Older people have been hearing about heart health from their doctors for years, and data show that smoking weed and consuming edibles can have catastrophic cardiovascular effects. The findings connecting marijuana use to increased rates of dementia in the general population will hit hard with seniors, too. Doctors need to be raising this information with their older patients at least at every checkup. People should spread the news to their own parents (in as gentle a way as possible). Today's weed isn't your grandparents' weed, after all. There also needs to be more research into the specific risks marijuana poses to those aged 65 and over, given that data suggest its general risks grow worse with age. People could be tempted to laugh off the idea of stopping silver-haired grannies from getting high. But this is a deadly serious issue. Marijuana is dangerous, no matter your age. It's time America woke up to that fact and started talking about it—even if it means some hard conversations with mom and dad at your Fourth of July BBQ. Dr. Kevin Sabet is the president and CEO of Smart Approaches to Marijuana. The views expressed in this article are the writer's own.
Bloomberg
a day ago
- Bloomberg
Not All Ritalin Is Created Equal: Why Some Generics Fail to Work
Stanford University researchers have discovered why some people with attention deficit hyperactivity disorder may do well on their medicine for a while but struggle down the road. Researchers tested how generic Ritalin and other versions of the drug known as methylphenidate dissolve and found some dissipated much more quickly or slowly than they should have, according to a study, the final version of which is set to be published in the Journal of the American Academy of Child and Adolescent Psychiatry.
Yahoo
a day ago
- Yahoo
ADHD waiting list led to rise in unregulated private providers
NHS waiting lists for ADHD diagnosis and support have led to a 'significant growth in the use of private providers that are not regulated', a taskforce has said. The ADHD taskforce, commissioned by NHS England with the support of the Government, has published an interim report saying the system for diagnosing and managing ADHD needs to be overhauled. At the moment, ADHD assessment and treatment in England is provided by highly specialised doctors in secondary care. But the report warned: 'Inability to access NHS services has led to a significant growth in the use of private providers that are not regulated, resulting in two-tier access to services, diagnosis and treatment; one for those who can pay and another for those who cannot. 'This drives health inequalities and links to disproportionate impacts and outcomes in the education and justice systems, employment and health.' Experts behind the study said waiting times for NHS ADHD services 'have escalated and are unacceptably long' and demand on services is 'very likely' to continue to rise. The taskforce concluded that ADHD is not solely the remit of the NHS and other health providers, with schools being vital for identifying and meeting needs at an early stage. And while a clinical diagnosis of ADHD via the NHS is required if a person needs medication, early support can still be provided to others. The report said: 'We need timely recognition and early support of suspected ADHD and neurodivergence across all settings. 'This is especially important in schools and the early years, to prevent adverse impacts and costly outcomes in the future. This should be needs-led and not require a clinical diagnosis.' The report also suggested there is no evidence of over-diagnosis of ADHD in the UK. It argued: 'England and the rest of the UK have much lower service recognition and treatment rates of ADHD diagnosis compared with other European countries. 'Recent data show a very high level of under-recognition and under-treatment of strictly diagnosed ADHD, with significant inequalities in access to care.' The report also addressed concerns about potential 'over-medicalisation and over-diagnosis', including worries that people are self-diagnosing ADHD based on information from social media. However, the report, said that 'currently there is no good evidence on what percentage of those waiting to see a clinician have self-diagnosed ADHD using social media and eventually meet or do not meet ADHD diagnostic criteria after a high-quality assessment. 'We only know currently that in England, recognised rates of ADHD are lower than the expected prevalence of ADHD.' Currently, the estimated economic costs of not treating ADHD are around £17 billion to the UK economy, the report went on. This includes through lower tax contributions, people needing state benefits and more likely to be not in education, employment or training, or who are long-term unemployed. 'Many of these costs are avoidable, as with appropriate, early support, people with ADHD can thrive,' it said. Professor Anita Thapar, chair of the ADHD Taskforce, said: 'The recommendations put forward by the taskforce will require action across Government and cross-sector organisations to make the necessary changes to improve the lives of people with ADHD. 'We need to get this right, to make sure people get early diagnosis and support, not just in the NHS but across society.' Dr Adrian James, NHS England's medical director for mental health and neurodiversity, said: 'We know that too many people with ADHD have been waiting for too long for support, which is why we launched the taskforce last year to help respond to the significant growth in the need for care. 'It is clear that much more needs to be done to improve ADHD assessment and care in England and ensure people can get a timely diagnosis, and we welcome the findings from the interim report, and look forward to its final conclusions later this year.' The NHS has launched publicly-available data collection on ADHD referrals and waiting times to help local teams better understand how they are performing. By March 2026, the Government also aims for six in 10 pupils to have access to a mental health support team in school.
